Search | Médecins Sans Frontières Access Campaign

266 results found
There is 1 active filter
Clear all filters
Statement

266 results found

Statement |

12 September 2018

MSF Statement on the WHO Roadmap for access 2019 -2023: Comprehensive support for access to medicines and vaccines

Tags Research and development Doha Declarationintellectual property & tradeUN High Level Panel on Access to Medicines World Health Organization

Statement |

22 May 2018

MSF Response to the launch of the Global Research & Development Collaboration Hub for Antimicrobial Resistance (AMR)

Tags Drug-resistant infections antimicrobial resistance World Health AssemblyWorld Health Organization G20

Statement |

18 May 2018

MSF statement at 71st WHA: Preparation for a high-level meeting of the General Assembly on ending tuberculosis

Tags Tuberculosis tuberculosis World Health AssemblyWorld Health Organization

Statement |

18 May 2018

MSF statement at 71st WHA: Global snakebite burden

Tags Tropical & neglected diseases snakebite World Health AssemblyWorld Health Organization

Statement |

18 May 2018

MSF statement at 71st WHA: Global vaccine action plan

Tags Vaccines World Health AssemblyWorld Health Organization

Statement |

18 May 2018

MSF statement at 71st WHA: Global strategy and plan of action on public health, innovation and intellectual property

Tags Intellectual property and trade World Health AssemblyWorld Health Organization

Statement |

18 May 2018

MSF statement at 71st WHA: Addressing the global shortage of, and access to, medicines and vaccines

Tags Vaccines access to medicines World Health AssemblyWorld Health Organization

Statement |

30 April 2018

Members of European Parliament condemn PhRMA’s request to include the European Union to US "Special 301" watch list

Tags Intellectual property and trade imatinib

Statement |

13 March 2018

FP9 Public Consultation on EU funds in the area of investment, research & innovation, SME's and single market

Tags Research and development

Emmanuel Frances, 39 years from Nsamera Mozambique arrived at Nsanje district hospital with advanced HIV and related opportunistic infections cryptococcal meningitis and TB. He underwent a lumbar puncture to evacuate fluid creating pressure in the spinal column and brain caused by cryptococcal meningitis, 2017, Malawi.

Statement |

07 March 2018

MSF Response to New WHO Guidelines for HIV-Related Cryptococcal Disease

Tags HIV/AIDS cryptococcal meningitis

Statement |

24 January 2018

142nd WHO EB Agenda item 6.2 Global vaccine action plan

Tags Vaccines WHO Executive BoardWorld Health AssemblyWorld Health Organization

Statement |

24 January 2018

142nd WHO EB Agenda item 4.1 - Global snakebite burden statement

Tags Tropical & neglected diseases WHO Executive BoardWorld Health AssemblyWorld Health Organization

Statement |

24 January 2018

142nd WHO EB Agenda item 3.9 - Preparation for a high-level meeting of the General Assembly on ending tuberculosis

Tags Tuberculosis WHO Executive BoardWorld Health AssemblyWorld Health Organization

Statement |

24 January 2018

142nd WHO EB Agenda item 3.7 - Global strategy and plan of action on public health, innovation and intellectual property

Tags Intellectual property and tradeResearch and development WHO Executive BoardWorld Health AssemblyWorld Health Organization

Statement |

24 January 2018

142nd WHO EB Agenda item 3.6 - Addressing the global shortage of, and access to, medicines and vaccines

Tags Vaccines WHO Executive BoardWorld Health AssemblyWorld Health Organization

Statement |

06 December 2017

MSF Remarks at WHO Global Ministerial Conference on Ending TB in the Sustainable Development Era

Tags Tuberculosis tuberculosis World Health Organization #StepUpforTB

Statement |

14 September 2017

MSF statement at the 67th session of the WHO Regional Committee for Europe

Tags Tuberculosis drug-resistant TB innovationresearch and development (R&D)UN High Level Panel on Access to Medicines World Health Organization

Statement |

22 May 2017

70th World Health Assembly intervention, Agenda Item 12.1

Tags Research and development research and development (R&D) World Health AssemblyWorld Health Organization

Statement |

22 May 2017

70th World Health Assembly Intervention, Agenda Item 13.5

Tags CEWGresearch and development (R&D) World Health AssemblyWorld Health Organization

Statement |

22 May 2017

70th World Health Assembly Intervention, Agenda Item 13.4

Tags innovationresearch and development (R&D) World Health AssemblyWorld Health Organization

Date

Primary topics

Types of content

Products

Diseases

General Terms

Geography

Campaigns

Institutions & Events

Report series

Miscellaneous

MSF Statement on the WHO Roadmap for access 2019 -2023: Comprehensive support for access to medicines and vaccines

MSF Response to the launch of the Global Research & Development Collaboration Hub for Antimicrobial Resistance (AMR)

MSF statement at 71st WHA: Preparation for a high-level meeting of the General Assembly on ending tuberculosis

MSF statement at 71st WHA: Global snakebite burden

MSF statement at 71st WHA: Global vaccine action plan

MSF statement at 71st WHA: Global strategy and plan of action on public health, innovation and intellectual property

MSF statement at 71st WHA: Addressing the global shortage of, and access to, medicines and vaccines

Members of European Parliament condemn PhRMA’s request to include the European Union to US "Special 301" watch list

FP9 Public Consultation on EU funds in the area of investment, research & innovation, SME's and single market

MSF Response to New WHO Guidelines for HIV-Related Cryptococcal Disease

142nd WHO EB Agenda item 6.2 Global vaccine action plan

142nd WHO EB Agenda item 4.1 - Global snakebite burden statement

142nd WHO EB Agenda item 3.9 - Preparation for a high-level meeting of the General Assembly on ending tuberculosis

142nd WHO EB Agenda item 3.7 - Global strategy and plan of action on public health, innovation and intellectual property

142nd WHO EB Agenda item 3.6 - Addressing the global shortage of, and access to, medicines and vaccines

MSF Remarks at WHO Global Ministerial Conference on Ending TB in the Sustainable Development Era

MSF statement at the 67th session of the WHO Regional Committee for Europe

70th World Health Assembly intervention, Agenda Item 12.1

70th World Health Assembly Intervention, Agenda Item 13.5

70th World Health Assembly Intervention, Agenda Item 13.4